Andreas Antzoulas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andreas Antzoulas has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Francesk Mulita
Department of General Surgery, General University Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece
5 shared publications - Elias Liolis
Department of Oncology, Department of Oncology, General University Hospital of Patras, Patras, Greece
4 shared publications - Konstantinos Tasios
Second Department of Psychiatry, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini St., 12462 Athens, Greece
3 shared publications - Levan Tchabashvili
Department of General Surgery, General Hospital of Aigio, Aigio, Greece
3 shared publications - Marios Platon Dimopoulos
Department of Interventional Radiology, University Hospital of Patras, 26504 Patras, Greece
3 shared publications - Vasileios Leivaditis
Department of Cardiothoracic and Vascular Surgery, Westpfalz Klinikum, 67655 Kaiserslautern, Germany
3 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 26 (3) , 303
Mental diseases in gastrointestinal cancer survivors: prevalence and impact on overall survival
- 29 October 2026
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 26 (3) , 303
Open AccessMental diseases in gastrointestinal cancer survivors: prevalence and impact on overall survival
- 22 December 2025
- Published by Elsevier in Clinical Imaging
- Vol. 130, 110704
The current role of cryoablation in the management of soft tissue and bone tumors: A narrative review
- 22 December 2025
- Published by Elsevier in Clinical Imaging
- Vol. 130, 110704
The current role of cryoablation in the management of soft tissue and bone tumors: A narrative review
- 28 February 2025
- Published by Hamad bin Khalifa University Press (HBKU Press) in Journal of Emergency Medicine, Trauma and Acute Care
- Vol. 2025 (1) , 10
Laparoscopic management of a large hepatic Echinococcosis granulosus cyst with concurrent cholelithiasis
Human echinococcosis (hydatidosis or hydatid) disease is a worldwide neglected zoonotic larval infection typically caused by cestodes of the Echinococcus genus. It affects 1 million people worldwide, predominantly reported in Central Asia, the Middle East, and South America. In this paper, we report a patient who underwent a successful laparoscopic partial pericystectomy and omentoplasty with simultaneous cholecystectomy in the treatment of cystic echinococcosis and cholelithiasis, respectively. There are many challenges to treating complicated hepatic hydatid cysts. It is crucial for surgeons to have knowledge of the range of possibilities of each surgical modality and its expanding advancements that can reduce complication risks and increase a patient’s quality of life. The art of sharing techniques and management possibilities between professionals in this field provides a bridge in further crafting the best-tailored treatment plan for patients. This report illustrates the successful usage of laparoscopy in the management of a section IV hydatid cyst with simultaneous cholecystectomy. This case aims to expand the knowledge and prospects of laparoscopic surgery in cystic echinococcosis.
- 28 February 2025
- Published by Hamad bin Khalifa University Press (HBKU Press) in Journal of Emergency Medicine, Trauma and Acute Care
- Vol. 2025 (1) , 10
Laparoscopic management of a large hepatic Echinococcosis granulosus cyst with concurrent cholelithiasis
Human echinococcosis (hydatidosis or hydatid) disease is a worldwide neglected zoonotic larval infection typically caused by cestodes of the Echinococcus genus. It affects 1 million people worldwide, predominantly reported in Central Asia, the Middle East, and South America. In this paper, we report a patient who underwent a successful laparoscopic partial pericystectomy and omentoplasty with simultaneous cholecystectomy in the treatment of cystic echinococcosis and cholelithiasis, respectively. There are many challenges to treating complicated hepatic hydatid cysts. It is crucial for surgeons to have knowledge of the range of possibilities of each surgical modality and its expanding advancements that can reduce complication risks and increase a patient’s quality of life. The art of sharing techniques and management possibilities between professionals in this field provides a bridge in further crafting the best-tailored treatment plan for patients. This report illustrates the successful usage of laparoscopy in the management of a section IV hydatid cyst with simultaneous cholecystectomy. This case aims to expand the knowledge and prospects of laparoscopic surgery in cystic echinococcosis.
- Open Access
- 16 December 2024
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 11 (12) , 395-398
Pain Scales: Types and Comparison
Objective: Pain is a common and significant symptom in clinical practice, particularly among emergency and cancer patients. This article explores various pain scales and their clinical applications, alongside postoperative pain management in oncologic patients. A review of unidimensional pain scales, including the Numeric Rating Scale (NRS), Visual Analog Scale (VAS), Verbal Rating Scale (VRS), and Faces Pain Rating Scale (FPS), is presented. Additionally, the pathophysiology and pharmacological and non-pharmacological strategies for managing postoperative pain in cancer patients are discussed. Pain scales vary in sensitivity, ease of use, and clinical suitability. NRS is widely preferred for its simplicity and statistical applicability, whereas VAS offers higher sensitivity but practical limitations. Postoperative pain in oncologic patients is influenced by surgical trauma, psychological factors, and pre-existing pain conditions, with inadequate management leading to systemic complications and increased cancer recurrence risk. Effective management incorporates both non-opioid and opioid analgesics based on pain severity. Pain assessment tools and effective management strategies are critical for improving patient outcomes in clinical settings. Tailored approaches, particularly in oncologic postoperative care, can mitigate complications and enhance quality of life.
- 16 December 2024
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 11 (12) , 395-398
Open AccessPain Scales: Types and Comparison
Objective: Pain is a common and significant symptom in clinical practice, particularly among emergency and cancer patients. This article explores various pain scales and their clinical applications, alongside postoperative pain management in oncologic patients. A review of unidimensional pain scales, including the Numeric Rating Scale (NRS), Visual Analog Scale (VAS), Verbal Rating Scale (VRS), and Faces Pain Rating Scale (FPS), is presented. Additionally, the pathophysiology and pharmacological and non-pharmacological strategies for managing postoperative pain in cancer patients are discussed. Pain scales vary in sensitivity, ease of use, and clinical suitability. NRS is widely preferred for its simplicity and statistical applicability, whereas VAS offers higher sensitivity but practical limitations. Postoperative pain in oncologic patients is influenced by surgical trauma, psychological factors, and pre-existing pain conditions, with inadequate management leading to systemic complications and increased cancer recurrence risk. Effective management incorporates both non-opioid and opioid analgesics based on pain severity. Pain assessment tools and effective management strategies are critical for improving patient outcomes in clinical settings. Tailored approaches, particularly in oncologic postoperative care, can mitigate complications and enhance quality of life.
- Open Access
- 16 December 2024
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 11 (12) , 399-401
Costs of Inflammatory markers worldwide and the use of Butyrylcholinesterase (BChE)
Objective: Butyrylcholinesterase (BChE) is an enzyme that shares similarities with acetylcholinesterase (AChE) but has been less studied due to its uncertain physiological role. Initially regarded as an ‘orphan enzyme,’ recent studies suggest that BChE plays a significant role in inflammation, primarily through its involvement in the cholinergic anti-inflammatory pathway. This enzyme, primarily produced by the liver, is found in several tissues and is known to hydrolyze acetylcholine, a neurotransmitter that modulates immune responses. BChE levels are influenced by various diseases, such as diabetes, cardiovascular diseases, and neurological disorders, which are associated with inflammation. This study reviews the costs of inflammatory biomarkers worldwide and investigates the association between BChE and inflammation. Data from multiple countries reveal varying costs for biomarkers like C-reactive protein (CRP), procalcitonin (PCT), and BChE, with BChE being a more cost-effective option in certain regions such as Greece and Armenia. Furthermore, BChE activity correlates inversely with the degree of systemic inflammation, and its levels may serve as a predictive marker for conditions such as surgical infections and anastomotic leaks. The findings underscore the potential of BChE as a useful and affordable biomarker for monitoring inflammation, particularly in settings where other biomarkers are more costly. However, further research is needed to validate its widespread clinical application.
- 16 December 2024
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 11 (12) , 399-401
Open AccessCosts of Inflammatory markers worldwide and the use of Butyrylcholinesterase (BChE)
Objective: Butyrylcholinesterase (BChE) is an enzyme that shares similarities with acetylcholinesterase (AChE) but has been less studied due to its uncertain physiological role. Initially regarded as an ‘orphan enzyme,’ recent studies suggest that BChE plays a significant role in inflammation, primarily through its involvement in the cholinergic anti-inflammatory pathway. This enzyme, primarily produced by the liver, is found in several tissues and is known to hydrolyze acetylcholine, a neurotransmitter that modulates immune responses. BChE levels are influenced by various diseases, such as diabetes, cardiovascular diseases, and neurological disorders, which are associated with inflammation. This study reviews the costs of inflammatory biomarkers worldwide and investigates the association between BChE and inflammation. Data from multiple countries reveal varying costs for biomarkers like C-reactive protein (CRP), procalcitonin (PCT), and BChE, with BChE being a more cost-effective option in certain regions such as Greece and Armenia. Furthermore, BChE activity correlates inversely with the degree of systemic inflammation, and its levels may serve as a predictive marker for conditions such as surgical infections and anastomotic leaks. The findings underscore the potential of BChE as a useful and affordable biomarker for monitoring inflammation, particularly in settings where other biomarkers are more costly. However, further research is needed to validate its widespread clinical application.